Join Growin Stock Community!

Progyny, inc.PGNY.US Overview

US StockHealthcare
(No presentation for PGNY)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PGNY AI Insights

PGNY Overall Performance

PGNY AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PGNY Recent Performance

0.79%

Progyny, inc.

0.05%

Avg of Sector

-0.31%

S&P500

PGNY PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PGNY Key Information

PGNY Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PGNY Profile

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Price of PGNY

PGNY FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PGNY Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.68
PE Ratio (TTM)
28.53
Forward PE
25.32
PS Ratio (TTM)
1.18
PB Ratio
2.72
Price-to-FCF
7.91
METRIC
VALUE
vs. INDUSTRY
Gross Margin
23.63%
Net Margin
4.54%
Revenue Growth (YoY)
10.40%
Profit Growth (YoY)
20.18%
3-Year Revenue Growth
14.10%
3-Year Profit Growth
20.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.68
PE Ratio (TTM)
28.53
Forward PE
25.32
PS Ratio (TTM)
1.18
PB Ratio
2.72
Price-to-FCF
7.91
Gross Margin
23.63%
Net Margin
4.54%
Revenue Growth (YoY)
10.40%
Profit Growth (YoY)
20.18%
3-Year Revenue Growth
14.10%
3-Year Profit Growth
20.00%
  • When is PGNY's latest earnings report released?

    The most recent financial report for Progyny, inc. (PGNY) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PGNY's short-term business performance and financial health. For the latest updates on PGNY's earnings releases, visit this page regularly.

  • Where does PGNY fall in the P/E River chart?

    According to historical valuation range analysis, Progyny, inc. (PGNY)'s current price-to-earnings (P/E) ratio is 24.76, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of PGNY?

    According to the latest financial report, Progyny, inc. (PGNY) reported an Operating Profit of 15.22M with an Operating Margin of 4.78% this period, representing a decline of 3.58% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is PGNY's revenue growth?

    In the latest financial report, Progyny, inc. (PGNY) announced revenue of 318.4M, with a Year-Over-Year growth rate of 6.69%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does PGNY have?

    At the end of the period, Progyny, inc. (PGNY) held Total Cash and Cash Equivalents of 112.24M, accounting for 0.15 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does PGNY go with three margins increasing?

    In the latest report, Progyny, inc. (PGNY) achieved the “three margins increasing” benchmark, with a gross margin of 24.1%%, operating margin of 4.78%%, and net margin of 3.9%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess PGNY's profit trajectory and future growth potential.

  • Is PGNY's EPS continuing to grow?

    According to the past four quarterly reports, Progyny, inc. (PGNY)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.14. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of PGNY?

    Progyny, inc. (PGNY)'s Free Cash Flow (FCF) for the period is 48.59M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 3.34% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of PGNY?

    The latest valuation data shows Progyny, inc. (PGNY) has a Price-To-Earnings (PE) ratio of 24.76 and a Price/Earnings-To-Growth (PEG) ratio of -7.01. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.